Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide's Effect on the Brain-Gut Axis in IBS-C
NCT02078323Completed
- Sponsor
- Augusta University
- Start
- Feb 2014
- Primary completion
- Oct 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Augusta University. Primary endpoint: Change from baseline in anal Cortical Evoked Potentials and rectal Cortical Evoked Potentials responses at 10 weeks. Started Feb 2014; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02078323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078323.